Kristopher Jonas: Listening to Patients and Recognizing the Donors Who Make Treatment Possible
Kristopher Jonas, Chief Executive Officer/President at Proesis Biologics, shared Plasma Protein Therapeutics Association‘s post on LinkedIn:
“International Plasma Awareness Week starts Monday.
My suggestion for anyone in this industry: start by listening to a patient.
I’ve spent my career on the collection side of plasma. From that seat, it’s easy for the work to become liters collected, yield, and cost per liter. Those numbers matter. They are not the point; the point is someone like Matthew who lives with Von Willebrand disease. For Matt, treatment means peace of mind around everyday experiences and the ability to focus on living life.
Matthew also knows there is another story behind every treatment: the donors whose generosity makes these medicines possible.
That’s the part I’d underline. Donors are not a supply input. They are people making a real commitment of time and body, often twice a week, and they deserve to be treated that way every time they walk through the door.
Hear Matthew’s perspective in the IPAW 2026 webinar ‘More Than Medicine: What Plasma Makes Possible for Patients.’
- October 5, 2026, 10 a.m. ET
- Live on YouTube.”
Plasma Protein Therapeutics Association (PPTA) shared a post on LinkedIn:
“Plasma-derived medicines can help patients move beyond the constant uncertainty that can accompany a bleeding disorder.
For Matthew Delaney, living with von Willebrand disease, treatment helps provide greater peace of mind around everyday experiences and the ability to focus on living life.
But Matt also knows that there is another story behind every treatment: the story of the plasma donors whose generosity makes these medicines possible.
Hear Matt’s perspective during the IPAW 2026 webinar: “More Than Medicine: What Plasma Makes Possible for Patients.”
- October 5, 2026, 10 a.m. ET
- Live on YouTube.”
Stay updated with Hemostasis Today.
-
Oct 17, 2026, 02:35Carly Newton: Understanding Access to Red Blood Cell Exchange for People Living With SCD
-
Oct 17, 2026, 02:34Raising Awareness of Blood Clots During and After Pregnancy – Thrombosis UK
-
Oct 17, 2026, 02:33Alaa Salamat: Our Research Accepted for Publication at ASH 2026
-
Oct 17, 2026, 02:32Mohammed Al Sharif: Discussing Factor XIII Testing and Its Clinical Significance
-
Oct 17, 2026, 02:31Joanna Popiolek-Kalisz: Talking about Novel Pharmacotherapy for Hypertension at CV Prevention and Intervention
-
Oct 17, 2026, 02:00How Antiphospholipid Syndrome Can Affect the Adrenal Glands – APS Foundation of America
-
Oct 17, 2026, 01:59Liza-Marie Johnson: How Far Should Clinicians Go to Influence Parents’ Decisions?
-
Oct 17, 2026, 01:54Jim Hoffman: The Importance of Self-Advocacy and Understanding Autoimmune Mechanisms
-
Oct 16, 2026, 18:12Adil Nawaz: Extended Dual Antiplatelet Therapy After Coronary Stenting